Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1. 请及时下载文件确认是否正确, 系统将在 2026-04-29 16:07:35 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s0140-6736(25)01811-2
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673625018112
其他信息:
出版社: Elsevier BV
作者: Shun Lu; Jie Wang; Nong Yang; Dongqing Lv; Lijuan Chen; Lin Wu; Xingya Li; Longhua Sun; Yongfeng Yu; Bo Jin; Lin Yang; Yubiao Guo; Haipeng Xu; Tienan Yi; Aiping Zeng; Xiaorong Dong; Jianhua Chen; Ziping Wang; Hongrui Niu; Ying Cheng; Pinhua Pan; Pengbo Deng; Hongming Pan; Xuhong Min; Jun Bai; Laiyu Liu; Tongmei Zhang; Juan Li; Songhua Fan; Michael M Shi; Tony Mok; Weiguo Su; Shun Lu; Jie Wang; Nong Yang; Dongqing Lv; Lijuan Chen; Lin Wu; Xingya Li; Longhua Sun; Yongfeng Yu; Bo Jin; Lin Yang; Yubiao Guo; Haipeng Xu; Tienan Yi; Aiping Zeng; Xiaorong Dong; Jianhua Chen; Ziping Wang; Hongrui Niu; Ying Cheng; Pinhua Pan; Pengbo Deng; Hongming Pan; Xuhong Min; Jun Bai; Laiyu Liu; Tongmei Zhang; Juan Li; Songhua Fan; Michael M. Shi; Tony Mok; Weiguo Su; Feng Ye; Xianling Liu; Jianhua Shi; Jiwei Liu; Qisen Guo; Weihua Yang; Junfang Tang; Shundong Cang; Ou Jiang; Jian Fang; Guohua Yu; Lijun Wang; Xibin Zhuang; Zhigang Han; Yiping Zhang; Zhengbo Song; Baogang Liu; Buhai Wang; Jianying Zhou; Wei Gu; Hongcheng Wu; Zhiwei Lu; Yan Yang; Wen Dong; Xiuhua Fu; Youling Gong; Jinhuo Lai; Ping Sun; Yingying Du; Zhihua Liu; Diansheng Zhong; Kaihua Lu; Jianghong Wang; Zhaohong Chen; Xiujie Cui; Zhengxiang Han; Yu Yao; Fang Zhang; Yunchao Huang; Haichuan Su; Zhennan Yi; Lin Li; Tongjian Cui; Puhan Lu; Xiangdong Wang; Jie Yu; Huan Yan; Xian Luo; Yongxin Ren
